AU6237396A - Interaction of p53 with transcription factor dp-1 - Google Patents

Interaction of p53 with transcription factor dp-1

Info

Publication number
AU6237396A
AU6237396A AU62373/96A AU6237396A AU6237396A AU 6237396 A AU6237396 A AU 6237396A AU 62373/96 A AU62373/96 A AU 62373/96A AU 6237396 A AU6237396 A AU 6237396A AU 6237396 A AU6237396 A AU 6237396A
Authority
AU
Australia
Prior art keywords
interaction
transcription factor
transcription
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62373/96A
Inventor
Nicholas Barrie La Thangue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU6237396A publication Critical patent/AU6237396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU62373/96A 1995-06-30 1996-06-28 Interaction of p53 with transcription factor dp-1 Abandoned AU6237396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9513342.7A GB9513342D0 (en) 1995-06-30 1995-06-30 Complexes
GB9513342 1995-06-30
PCT/GB1996/001560 WO1997002354A1 (en) 1995-06-30 1996-06-28 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1

Publications (1)

Publication Number Publication Date
AU6237396A true AU6237396A (en) 1997-02-05

Family

ID=10776918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62373/96A Abandoned AU6237396A (en) 1995-06-30 1996-06-28 Interaction of p53 with transcription factor dp-1

Country Status (6)

Country Link
EP (1) EP0835319A1 (en)
JP (1) JPH11509089A (en)
AU (1) AU6237396A (en)
CA (1) CA2224940A1 (en)
GB (1) GB9513342D0 (en)
WO (1) WO1997002354A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610195D0 (en) * 1996-05-15 1996-07-24 Medical Res Council Assay
US6159691A (en) * 1996-05-15 2000-12-12 Prolifix Limited Assay for a putative regulator of cell cycle progression
US6387649B1 (en) 1996-09-30 2002-05-14 Prolifix Limited Assay for a regulator of cell cycle progression
GB9724828D0 (en) * 1997-11-21 1998-01-21 Univ Glasgow Gene
FR2775003A1 (en) * 1998-02-19 1999-08-20 Transgene Sa Identifying compounds that inhibit interaction between STAT1 and USF1 peptides, for modulating gene expression, particularly of that encoding class II transactivator
EP1163341A2 (en) * 1999-03-19 2001-12-19 CropDesign N.V. Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
US8123977B2 (en) 2005-11-07 2012-02-28 Lg Chem, Ltd. Copolymer for liquid crystal alignment, liquid crystal aligning layer including copolymer for liquid crystal alignment, and liquid crystal display including liquid crystal aligning layer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333202T2 (en) * 1992-06-26 2004-03-18 The Trustees Of Princeton University METHOD FOR DETECTING CANCER CELLS OR THEIR STAGE BY P90 AND P53 ANTIBODIES OR P90 AND P53 PROBE

Also Published As

Publication number Publication date
GB9513342D0 (en) 1995-09-06
WO1997002354A1 (en) 1997-01-23
EP0835319A1 (en) 1998-04-15
JPH11509089A (en) 1999-08-17
CA2224940A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
AU6475996A (en) Wall form structure and methods for their manufacture
AU4237896A (en) Method and intermediates for the synthesis of korupensamines
AU4165993A (en) Aminediol compounds and derivatives and halohydrin intermediates
AU2498895A (en) 5-membered heteroaryl-oxazolidinones
AU1745995A (en) Composite sound wall
AU5379296A (en) Production of rhein and rhein derivatives
AU7317496A (en) Activation of p53 protein
AU6927996A (en) Closure
AUPN177495A0 (en) Improved closure
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU4943596A (en) Sulphonylaminocarbonyltriazolinones having halogenoalkenoxy substituents
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6237396A (en) Interaction of p53 with transcription factor dp-1
AU6284596A (en) Production of mono-n-alkyl-dinitroalkylanilines and n-alkyl-dinitroaniline derivatives
AU6175596A (en) Methods of modulating nf-kb transcription factor
AUPM806694A0 (en) Rendering of overlapping objects
AU4169796A (en) Recycling of coated paperboard
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU3948395A (en) Synthesis of 6-azaandrostenones
AU4241993A (en) Audio transducer improvements
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU1341497A (en) Pyrrolidine derivatives
AU4826096A (en) Tape
AU7231596A (en) Spacer
AU3178095A (en) Rendering of overlapping objects